CJC DAC 1295 2 Mg Hubio Pharm USA

CJC-1295 DAC – Extended-Release GHRH Peptide

Product Description:

CJC-1295 DAC is an advanced growth hormone-releasing hormone (GHRH) peptide engineered with a Drug Affinity Complex (DAC) to significantly extend its half-life. Unlike standard GHRH peptides, CJC-1295 DAC allows for sustained growth hormone (GH) and IGF-1 release for several days after a single injection. This makes it a popular choice for those seeking muscle growth, recovery, fat loss, and anti-aging benefits with fewer injections required.

Key Features

• Compound: CJC-1295 DAC (GHRH analog with extended half-life)

• Form: Injectable peptide

• Administration: Subcutaneous injection

• Injection Frequency: Only 1–2 times weekly

What is CJC-1295 DAC?

CJC-1295 DAC is a synthetic GHRH analog designed to stimulate the pituitary gland to naturally increase GH (Growth Hormone) and IGF-1 levels. The addition of the Drug Affinity Complex (DAC) dramatically increases its half-life, allowing for long-lasting activity and less frequent injections compared to other peptides.

This makes CJC-1295 DAC highly effective for:

• Muscle growth and repair

• Enhanced fat loss

• Improved sleep and recovery

• Anti-aging and collagen support

Benefits of CJC-1295 DAC

1. Long-lasting effects – reduces injection frequency to just 1–2 times per week.

2. Supports lean muscle growth – stimulates GH and IGF-1 naturally.

3. Accelerates recovery – improves muscle repair and endurance.

4. Boosts fat loss – enhances metabolism and fat oxidation.

5. Anti-aging support – collagen production, skin elasticity, and vitality.

Dosage and Administration

• Clinical Dose Range: 15–30mcg/kg per week

• Performance Enhancement Dose: 2000–5000mcg weekly

• Injection Frequency: 1–2 subcutaneous injections per week

 For optimal results, CJC-1295 DAC is often stacked with a GHRP peptide such as Ipamorelin to maximize GH pulse stimulation.

Possible Side Effects

CJC-1295 DAC is generally well tolerated, but possible side effects may include:

• Mild injection site irritation

• Water retention or bloating

• Headaches or fatigue

• Increased appetite (dose-dependent)